Blood and urine may hold clues to rare breathing condition
NCT ID NCT06997146
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to find biological markers in blood and urine that could explain congenital central hypoventilation syndrome (CCHS), a rare disorder where the brain fails to control breathing during sleep. Researchers will collect samples from 40 adults with CCHS and healthy volunteers during sleep and wakefulness. The goal is to identify disrupted pathways and potential targets for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Blood and urine sampling for biomarker analysis
- What this could lead to
- If successful, this could identify biological markers that help diagnose or predict CCHS progression, and reveal new targets for future treatments.
- What could go wrong
- This is an early-stage observational study with only 40 participants, so findings may not apply to all CCHS patients. It does not test any treatment directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL CENTRAL HYPOVENTILATION SYNDROME (CCHS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pitié-Salpêtrière Hospital
Paris, 75013, France